Edition:
United States

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

129.80EUR
7:03am EST
Change (% chg)

€1.30 (+1.01%)
Prev Close
€128.50
Open
€128.50
Day's High
€130.05
Day's Low
€128.20
Volume
2,718
Avg. Vol
6,673
52-wk High
€223.80
52-wk Low
€127.00

VIRB.PA

Chart for VIRB.PA

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 0.84
Market Cap(Mil.): €1,088.12
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  VIRB.PA Industry Sector
P/E (TTM): 41.19 29.13 29.87
EPS (TTM): 3.12 -- --
ROI: 2.62 15.56 14.95
ROE: 6.03 16.69 16.29

BRIEF-Virbac Q3 revenue rises to 216.3 million euros

* Reported on Thursday 9-month revenue 646.2 million euros ($723.81 million) versus 646.0 million euros year ago

Oct 14 2016

UPDATE 1-Virbac cuts revenue forecast on U.S., Chile market conditions

Sept 19 French veterinary pharmaceutical firm Virbac reported a jump in first-half earnings on Monday but trimmed its 2016 revenue growth forecasts due to difficulties in the United States and Chile, as well as a negative currency impact.

Sep 19 2016

BRIEF-Virbac H1 revenue down 0.5 pct at 430.0 million euros

* H1 revenue 430.0 million euros ($480.61 million) versus 432.3 million euros year ago

Sep 19 2016

BRIEF-Virbac Q2 revenue up at 218.6 mln euros

* Reports Q2 revenue of 218.6 million euros ($242.1 million) versus 220.9 million euros a year ago

Jul 18 2016

Earnings vs. Estimates